Research Scientist
NYU Langone
Aditya Deshpande, PhD is a computational biologist advancing the clinical utility of whole-genome sequencing in oncology. He co-leads the development of the genome Oncology System (gOS) at NYU Langone Health—an end-to-end molecular interpretation platform that transforms raw sequencing data into actionable clinical insights. Previously at Isabl Inc., he spearheaded the creation of GxT Heme, a production-grade WGS pipeline for hematologic malignancies, and built HemeDB, a curated knowledgebase of myeloid and lymphoid mutations.
Aditya earned his PhD in Computational Biology & Medicine from Cornell University, where he co-developed Pore-C for multi-way chromatin contact sequencing and authored several high-impact publications in Nature, Nature Genetics, Nature Biotechnology, and Nature Medicine. Trained as a physician (MBBS, MUHS India) and an epidemiologist (MPH, UTHealth Houston), he bridges clinical context with large-scale genomics, specializing in structural variation, copy number analysis, and data integration across WGS, RNA-seq, single-cell, and optical mapping modalities.
With experience spanning academia, biotech, and clinical translation, Aditya’s work centers on bringing high-resolution genome analysis into everyday cancer diagnostics—building the computational infrastructure and validation frameworks needed to make WGS a practical, clinical-grade tool.